ADAPT Micro-Randomized Trial
ADAPT MRT
2 other identifiers
interventional
60
1 country
1
Brief Summary
The goal of this study is to collect quantitative and qualitative data that can be used to optimize the HeartSteps mHealth intervention for physical activity. The current version of the intervention is intended to help patients with heart disease increase and maintain their physical activity long-term. To accomplish this goal, a 3-month pilot micro-randomized trial (MRT) will be conducted with 60 patients who are currently completing or have recently completed phase II cardiac rehabilitation (CR). The core of the study participation is the use of the HeartSteps intervention over the course of 3 months. This includes wearing the Fitbit Charge activity tracker during waking hours and using the HeartSteps intervention to support their efforts to be active. The HeartSteps intervention consists of two sets of intervention components: (1) components intended to improve participants' affective associations with physical activity, including activity suggestions designed to to trigger positive feelings and associate them with being active, and prompts to bring their awareness to intrinsically motivating aspects of being active; and (2) components that target reflective self-regulatory processes, including graphs for self-monitoring, prompts to plan activity, and weekly activity goals. How exactly, and how much, participants will use HeartSteps will not be prescribed since our goal is to understand naturalistic trajectory of engagement with the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cardiovascular-diseases
Started May 2025
Shorter than P25 for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2025
CompletedFirst Posted
Study publicly available on registry
April 8, 2025
CompletedStudy Start
First participant enrolled
May 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedSeptember 4, 2025
August 1, 2025
10 months
April 1, 2025
August 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weekly number of minutes of moderate to vigorous physical activity
The primary outcome of the study is number of weekly minutes of moderate to vigorous physical activity (MVPA), as assessed by the Fitbit Charge 6 activity tracker. Primary analysis will assess the difference in MVPA between the baseline week and the last (i.e. 12th) week of the study.
Baseline, 12 weeks
Secondary Outcomes (3)
3-hour step count
12 weeks
Daily step count
12 weeks
Affective exercise experiences (AFFEXX) scale
Baseline, 12 weeks
Study Arms (1)
Intervention
EXPERIMENTALParticipants receive the HeartSteps mHealth intervention for 3 months to support and increase physical activity. Components include: 1. Activity Suggestions: Push notifications encouraging walks, randomized twice daily (probability 0.5). 2. Morning Salience Messages: Notifications highlighting positive aspects of activity, randomized daily (probability 0.5). 3. Planning Prompts: Notifications to plan next day's activity, randomized daily (probability 0.5). 4. Weekly Reflection: Prompts each Sunday to reflect on past activity, set goals, and plan for the next week. 5. Pull Interventions: In-app features like activity dashboards and planning tools. 6. Ecological Momentary Assessments (EMA): Daily and weekly surveys on psychosocial constructs related to physical activity. Participants wear a Fitbit Charge tracker to monitor activity, synced to their MyDataHelps account. The intervention aims to optimize engagement and physical activity levels.
Interventions
HeartSteps is an innovative mobile health (mHealth) app designed for cardiac rehabilitation patients. The app features dynamic push notifications, daily and weekly surveys to capture psychosocial data, and an in-app dashboard that provides feedback on activity levels, goal progress, and reminders. Integrated with a Fitbit Charge tracker, HeartSteps emphasizes behavioral changes through engaging features. The intervention is personalized to meet individual needs and preferences, enhancing patient engagement and promoting sustained physical activity.
Eligibility Criteria
You may qualify if:
- Must be a patient within the Michigan Medicine clinical system with data available in the electronic health record after January 1, 2020.
- Age \> 18
- Owns and is a daily user of an Android or iPhone smartphone with study supported operating software.
- Understands English to enable informed consent, completion of study-related surveys, and compliance with study notifications.
- Will be completing within 30 days or have completed in the last 30 days the cardiac rehabilitation program at Michigan Medicine based on one of the following indications:
- Coronary artery disease (including acute coronary syndromes and stable angina) following percutaneous coronary intervention (PCI)
- Coronary artery disease following coronary artery bypass surgery (CABG)\]
- Valve repair or replacement (either surgical or percutaneous)
- Coronary artery disease or an acute coronary syndrome not requiring revascularization
You may not qualify if:
- Orthopedic or neurological condition limiting ability to actively engage in moderate intensity physical activity (e.g., brisk walking)
- Greater than mild cognitive impairment
- Wrist too large to wear an activity tracker comfortably. This will be assessed by asking participants "If they have ever had difficulty wearing a watch in the past due to the band being too small."
- Currently receiving palliative care and/or in hospice care
- Severe valvular stenosis or regurgitation
- Unrevascularized left main coronary artery disease (\> 50% obstruction on angiography) or proximal left anterior descending disease (\>70% obstruction on angiography).
- Exercise-induced ventricular tachycardia
- Cardiac arrest within the prior 6 months
- New York Heart Association (NYHA) class III or IV heart failure
- Pulmonary arterial hypertension treated with inhaled or intravenous pulmonary hypertension-specific therapy
- Ejection fraction \<40%
- Determined to be unsafe for participation in this program as assessed by a clinical nurse or investigative team.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Information
Study Record Dates
First Submitted
April 1, 2025
First Posted
April 8, 2025
Study Start
May 20, 2025
Primary Completion
March 1, 2026
Study Completion
March 1, 2026
Last Updated
September 4, 2025
Record last verified: 2025-08